Vaccine candidate against Chikungunya fever

A prophylactic vaccine candidate against Chikungunya fever, developed by Themis Bioscience GmbH, “induces a significant neutralising immune response and was also confirmed as safe.”
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: Infectious Disease Chikungunya fever Latest News prophylactic vaccine candidate Themis Bioscience GmbH Source Type: news